IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 38,650
-600 (-1.53%)
At close: Apr 29, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 558.07 billion as of April 30, 2026.
Market Cap
558.07B
Enterprise Value
537.48B
Revenue
2.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
38,650.00
Market Cap Chart
Since May 23, 2025, IntoCell's market cap has increased from 492.33B to 558.07B, an increase of 13.35%. That is a compound annual growth rate of 14.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 580.60B | -32.57% |
| Dec 30, 2025 | 861.05B | 74.89% |
| May 23, 2025 | 492.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curocell | 881.76B |
| Inventage Lab | 816.55B |
| IMBiologics | 718.12B |
| Kanaph Therapeutics | 504.08B |
| S.Biomedics | 456.39B |
| HansBiomed | 419.28B |
| TiumBio | 393.76B |
| Kangstem Biotech | 379.98B |